Circadian variations in blood pressure and their implications for the administration of antihypertensive drugs: is dosing in the evening better than in the morning?

被引:23
作者
Burnier, Michel [1 ]
Kreutz, Reinhold [2 ,3 ,4 ]
Narkiewicz, Krzysztof [5 ]
Kjeldsen, Sverre [6 ]
Oparil, Suzanne [7 ]
Mancia, Giuseppe [8 ]
机构
[1] CHU Vaudois, Serv Nephrol & Hypertens, Lausanne, Switzerland
[2] Charite Univ Med Berlin, Berlin, Germany
[3] Humboldt Univ, Freie Univ Berlin, Berlin, Germany
[4] Berlin Inst Hlth, Inst Klin Pharmakol & Toxikol, Berlin, Germany
[5] Med Univ Gdansk, Dept Hypertens & Diabetol, Gdansk, Poland
[6] Univ Oslo, Ullevaal Hosp, Dept Cardiol, Oslo, Norway
[7] Univ Alabama Birmingham, Dept Med, Vasc Biol & Hypertens Programme, Birmingham, AL 35294 USA
[8] Univ Milano Bicocca, Milan, Italy
关键词
bedtime; clinical trials; dipping; drug administration; nocturnal blood pressure; CONVERTING-ENZYME-INHIBITOR; CHRONIC KIDNEY-DISEASE; HYPERTENSIVE PATIENTS; CARDIOVASCULAR RISK; PROGNOSTIC VALUE; GENERAL-POPULATION; SLEEP-APNEA; CARDIORENAL PROTECTION; THERAPEUTIC TARGET; ACTIVE TREATMENT;
D O I
10.1097/HJH.0000000000002532
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Blood pressure (BP) follows a circadian rhythm with a physiological decrease during the night. Studies have demonstrated that nocturnal BP as well as its dipping pattern during night-time have a significant prognostic importance for mortality and the occurrence of cardiovascular events. Therefore, hypertension management guidelines recommend to ascertain that patients treated for hypertension have well controlled BP values around the clock. To improve hypertension control during the night and eventually further reduce cardiovascular events, it has been proposed by some to prescribe at least one antihypertensive medication at bedtime. In this review, we have examined the data which could support the benefits of prescribing BP-lowering drugs at bedtime. Our conclusion is that there is no convincing evidence that the administration of BP-lowering drugs in the evening provides any significant advantage in terms of quality of BP control, prevention of target organ damage or reduction of cardiovascular events. Before changing practice for unproven benefits, it would be wise to wait for the results of the ongoing trials that are addressing this issue.
引用
收藏
页码:1396 / 1406
页数:11
相关论文
共 100 条
  • [91] Increased nighttime blood pressure or nondipping profile for prediction of cardiovascular outcomes
    Tsioufis, C.
    Andrikou, I.
    Thomopoulos, C.
    Syrseloudis, D.
    Stergiou, G.
    Stefanadis, C.
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2011, 25 (05) : 281 - 293
  • [92] NONINVASIVE AUTOMATIC BLOOD-PRESSURE MONITORING DOES NOT ATTENUATE NIGHTTIME HYPOTENSION - EVIDENCE FROM 24H INTRAARTERIAL BLOOD-PRESSURE MONITORING
    VILLANI, A
    PARATI, G
    GROPPELLI, A
    OMBONI, S
    DIRIENZO, M
    MANCIA, G
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1992, 5 (10) : 744 - 747
  • [93] Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories
    Vrijens, Bernard
    Vincze, Gabor
    Kristanto, Paulus
    Urquhart, John
    Burnier, Michel
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2008, 336 (7653): : 1114 - 1117
  • [94] Evening versus morning dosing regimen drug therapy for chronic kidney disease patients with hypertension in blood pressure patterns: a systematic review and meta-analysis
    Wang, Caixia
    Ye, Yuqiu
    Liu, Chunyong
    Zhou, Yongming
    Lv, Linsheng
    Cheng, Cailian
    Li, Shaomin
    Lou, Tanqi
    Liu, Xun
    [J]. INTERNAL MEDICINE JOURNAL, 2017, 47 (08) : 900 - 906
  • [95] Prognostic Effect of Isolated Nocturnal Hypertension in Chinese Patients With Nondialysis Chronic Kidney Disease
    Wang, Cheng
    Li, Yan
    Zhang, Jun
    Ye, Zengchun
    Zhang, Qunzi
    Ma, Xinxin
    Peng, Hui
    Lou, Tanqi
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (10):
  • [96] 2018 ESC/ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension
    Williams, Bryan
    Mancia, Giuseppe
    Spiering, Wilko
    Rosei, Enrico Agabiti
    Azizi, Michel
    Burnier, Michel
    Clement, Denis L.
    Coca, Antonio
    de Simone, Giovanni
    Dominiczak, Anna
    Kahan, Thomas
    Mahfoud, Felix
    Redon, Josep
    Ruilope, Luis
    Zanchetti, Alberto
    Kerins, Mary
    Kjeldsen, Sverre E.
    Kreutz, Reinhold
    Laurent, Stephane
    Lip, Gregory Y. H.
    McManus, Richard
    Narkiewicz, Krzysztof
    Ruschitzka, Frank
    Schmieder, Roland E.
    Shlyakhto, Evgeny
    Tsioufis, Costas
    Aboyans, Victor
    Desormais, Ileana
    [J]. JOURNAL OF HYPERTENSION, 2018, 36 (10) : 1953 - 2041
  • [97] Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout
    Würzner, G
    Gerster, JC
    Chiolero, A
    Maillard, M
    Fallab-Stubi, CL
    Brunner, HR
    Burnier, M
    [J]. JOURNAL OF HYPERTENSION, 2001, 19 (10) : 1855 - 1860
  • [98] Yusuf S, 2000, NEW ENGL J MED, V342, P145
  • [99] Time of administration important? Morning versus evening dosing of valsartan
    Zappe, Dion H.
    Crikelair, Nora
    Kandra, Albert
    Palatini, Paolo
    [J]. JOURNAL OF HYPERTENSION, 2015, 33 (02) : 385 - 392
  • [100] Evening versus morning dosing regimen drug therapy for hypertension
    Zhao, Ping
    Xu, Ping
    Wan, Chaomin
    Wang, Zhengrong
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (10):